(Q40486578)

English

HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase (English)

1 reference

Europe PubMed Central

20 September 2017

0 references

author name string

De Clercq E

1

1 reference

Europe PubMed Central

20 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 1993

1 reference

Europe PubMed Central

20 September 2017

Medicinal Research Reviews

1 reference

Europe PubMed Central

20 September 2017

13

1 reference

Europe PubMed Central

20 September 2017

3

1 reference

Europe PubMed Central

20 September 2017

229-258

1 reference

Europe PubMed Central

20 September 2017

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610130303

21 January 2018

Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivatives

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610130303

21 January 2018

L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610130303

21 January 2018

[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610130303

21 January 2018

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610130303

21 January 2018

Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610130303

21 January 2018

Identifiers

10.1002/MED.2610130303

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40486578&oldid=1898101432"